Department of Psychiatry and Psychology, Mayo Clinic, west 11, 200 First St., SW, Rochester, MN 55905, USA.
J Anxiety Disord. 2012 Jan;26(1):111-6. doi: 10.1016/j.janxdis.2011.10.002. Epub 2011 Oct 7.
This study describes the validation of the obsessive compulsive subscale on the Spence Children's Anxiety Scale (SCAS OCD) for use as a clinical assessment tool. Data from 196 anxious children (102 males, ages 7-18) and their parent collected during a diagnostic assessment were compared to data from 420 children (206 males, ages 8-13) from the community collected by mail. The validity of the SCAS OCD parent- and child-report forms were supported by correlations with the Children's Yale-Brown Obsessive Compulsive Scale and continuous OCD symptom variables from the Anxiety Disorders Interview Schedule: Child Version. In addition, children with OCD were found to have higher scores on the SCAS OCD subscale than patients without OCD and children from the community without a reported anxiety diagnosis. The sensitivity of the SCAS OCD to treatment effects was also demonstrated in a subset of the clinical sample that received exposure and response prevention therapy. Finally, cut-scores were identified that examine the sensitivity and predictive utility of the scales.
本研究描述了 Spence 儿童焦虑量表(SCAS OCD)中强迫症分量表的验证,将其用作临床评估工具。在诊断评估中收集的 196 名焦虑儿童(102 名男性,年龄 7-18 岁)及其父母的数据与通过邮件从社区收集的 420 名儿童(206 名男性,年龄 8-13 岁)的数据进行了比较。SCAS OCD 父母报告和儿童报告形式的有效性通过与儿童耶鲁-布朗强迫症量表和焦虑障碍访谈表:儿童版的连续 OCD 症状变量的相关性得到支持。此外,与没有 OCD 的患者和没有报告焦虑诊断的社区儿童相比,患有 OCD 的儿童在 SCAS OCD 分量表上的得分更高。在接受暴露和反应预防治疗的临床样本亚集中,也证明了 SCAS OCD 对治疗效果的敏感性。最后,确定了用于检查量表的敏感性和预测效用的分界值。